Cargando…
GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma
BACKGROUND: Pancreatic adenocarcinoma (PAAD) is a disease with atypical symptoms, an unfavorable response to therapy, and a poor outcome. Abnormal guanylate-binding proteins (GBPs) play an important role in the host’s defense against viral infection and may be related to carcinogenesis. In this stud...
Autores principales: | Liu, Bo, Huang, Rongfei, Fu, Tingting, He, Ping, Du, Chengyou, Zhou, Wei, Xu, Ke, Ren, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121056/ https://www.ncbi.nlm.nih.gov/pubmed/34026364 http://dx.doi.org/10.7717/peerj.11423 |
Ejemplares similares
-
Dipeptidyl peptidase like 6 promoter methylation is a potential prognostic biomarker for pancreatic ductal adenocarcinoma
por: Zhao, Xin, et al.
Publicado: (2020) -
Identification of prognostic splicing factors and exploration of their potential regulatory mechanisms in pancreatic adenocarcinoma
por: Rong, Min-hua, et al.
Publicado: (2020) -
The nine ADAMs family members serve as potential biomarkers for immune infiltration in pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2020) -
Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma
por: Shi, Ting, et al.
Publicado: (2022) -
Identifying MMP14 and COL12A1 as a potential combination of prognostic biomarkers in pancreatic ductal adenocarcinoma using integrated bioinformatics analysis
por: Ding, Jingyi, et al.
Publicado: (2020)